A Phase II study of Decitabine in patients with Chronic Myelomonocytic Leukemia.
Phase of Trial: Phase II
Latest Information Update: 03 Jul 2012
At a glance
- Drugs Decitabine (Primary)
- Indications Chronic myelomonocytic leukaemia
- Focus Therapeutic Use
- 03 Jul 2012 Company added in the association field as reported by EudraCT.
- 27 Jul 2011 New trial record